In HCM-stimulated TAMs, SIRT4 silencing: (i) promotes IL-10 expression but also promotes the production of cytokines, including IL-6 and vascular endothelial growth factor, which have been reported to prompt tumor progression; (ii) inhibits IL-12 production, enhances anti-tumor immunity, and prevents cancer development. This evidence concerns the gene VEGFA and neoplasm.